Cargando…
Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management
Essure (Bayer) received approval from the U.S. Food and Drugs Administration as a permanent non-hormonal contraceptive implant in November 2002. While the use of Essure in the management of hydrosalpinx prior to in vitro fertilization (IVF) remains off-label, it has been used specifically for this p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Reproductive Medicine
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604296/ https://www.ncbi.nlm.nih.gov/pubmed/26473113 http://dx.doi.org/10.5653/cerm.2015.42.3.126 |